2021, Scientific Sessions, Session Coverage
  • Providers urged to consider mental health of diabetes patients & their caregivers

    Providers urged to consider mental health of diabetes patients & their caregivers

    David G. Marrero, PhD, advocated for a social-ecological model to better understand and integrate diabetes care in a symposium focused on preserving mental health across the lifespan of living with this disease.


  • Technology brings rapid changes to diabetes education and care

    Technology brings rapid changes to diabetes education and care

    Kelly M. Rawlings, MS, and Marci Butcher, RD, LN, CDCES, FADCES, will discuss digital health and diabetes support in a two-hour symposium Monday afternoon.


  • Panelists to examine behavioral and psychosocial aspects of diabetes tech

    Panelists to examine behavioral and psychosocial aspects of diabetes tech

    Maureen Monaghan, PhD, CDCES, Samantha Kleinberg, PhD, and Jennifer Raymond, MD, MCR, will offer insight into navigating the diabetes digital landscape.


  • T cell research may pave the way for diabetes immunotherapy

    T cell research may pave the way for diabetes immunotherapy

    An expert panel including Kathryn Haskins, PhD, Teresa P. DiLorenzo, PhD, and Megan K. Levins, PhD, will discuss the past, present, and future of T cells in diabetes treatment.


  • Public health experts will review environmental factors that contribute to diabetes, obesity

    Public health experts will review environmental factors that contribute to diabetes, obesity

    Carlos A. Monteiro, MD, PhD, will share data on the effects of ultraprocessed foods, while Sung Kyun Park, ScD, MPH, will provide data on per- and polyfluoroalkyl substances.


  • Despite new findings, questions persist about cause and consequences of neonatal hypoglycemia

    Despite new findings, questions persist about cause and consequences of neonatal hypoglycemia

    Raghavendra Rao, MD, Charles Stanley, MD, Sarbattama Sen, MD, and Paul Rozance, MD, will address whether neonatal hypoglycemia is overdiagnosed or underestimated in this symposium.


  • Experts will weigh benefits, challenges of type 1 diabetes screening

    Experts will weigh benefits, challenges of type 1 diabetes screening

    A joint symposium of the ADA and the International Society for Pediatric and Adolescent Diabetes featuring Richard A. Oram, MD, PhD, and R. Brett McQueen, PhD, will consider general population screening versus targeted screening.


  • Session will outline practical steps for effective use of CGM in primary care

    Session will outline practical steps for effective use of CGM in primary care

    The data from continuous glucose monitoring devices can help patients make more informed decisions on lifestyle modifications, insulin dosing, and meal planning. Thomas W. Martens, MD, Dana Gershenoff, MS, RD, CDCES, and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, explain how.


  • Presenter Perspectives: Looping is for Everyone … Who Wants to Do It

    Presenter Perspectives: Looping is for Everyone … Who Wants to Do It

    Dana M. Lewis, BA, shared details about her presentation at the 81st Scientific Sessions on evidence supporting the use of open-source automated insulin delivery systems. “Many providers are still unaware of them as an option, or how they might support patients choosing to access these systems,” she said.


  • Presenter Perspectives: Stem Cell-Based Drug Discovery for Precision Medicine of Diabetes

    Presenter Perspectives: Stem Cell-Based Drug Discovery for Precision Medicine of Diabetes

    Shuibing Chen, PhD, shared details about this presentation, which begins Sunday, June 27, at 6:00 p.m. ET.